The introduction of intensive coronary care has generally reduced the hospital mortality after acute myocardial infarction from 30 per cent with regular hospital care to below 20 per cent with intensive coronary care (Lawrie et al., I967; Lown et al., I967; Oliver, Julian, and Donald, I967; Sloman, I968) . It has been accepted that the major part of this improvement in mortality is due to the detection and successful treatment of the potentially fatal cardiac arrhythmias such as ventricular fibrillation (Lown et al., I967) . Though the risk of developing ventricular fibrillation is greatest soon after the onset of myocardial infarction (Pantridge and Geddes, I967) , it has been repeatedly shown that there is often a delay of several hours in admitting a patient to hospital (Mittra, I965; McNeilly and Pemberton, I968; Moss, Wynar, and Goldstein, I969). As a result, the majority of deaths from coronary thrombosis occur outside hospital (McNeilly and Pemberton, I968). Pantridge and Geddes (I966, I967) On receipt of the call at the coronary care unit, the ambulance station is contacted and the coronary ambulance dispatched to pick up the coronary team at the hospital. On arrival at the patient's house the first procedure is to connect the patient to the oscilloscope ensuring immediate supervision of cardiac rhythm. Arrhythmias are treated along prescribed lines with suppressive drugs, and cardiac arrest dealt with by external cardiac massage and mouth-to-mouth respiration, followed by defibrillation for ventricular fibrillation, and intracardiac adrenaline and calcium chloride for asystole. Heart failure and cardiogenic shock are also treated at home and the patient will be returned to hospital only when his clinical condition is satisfactory. Doubtful cases of myocardial infarction are always brought back to hospital for further assessment. The patient remains monitored continuously in the ambulance on the return journey. Before the ambulance is returned to the station, all equipment is checked for battery state; these are replaced if exhausted, and any drugs or intravenous fluids used are replaced, so that the ambulance is in a state of complete readiness for the next call. was also the most frequent of all supraventricular arrhythmias, usually associated with inferior infarction (5o%) and was successfully treated in all cases with intravenous atropine o-6 to I 2 mg. Heart block, occurring in 9 per cent of the patients, was also most commonly associated with inferior infarction (42%). Complete heart block was most common (ii patients) with left bundle-branch block close behind (io patients), followed by right bundlebranch block (6 patients) and first-degree block (5 patients). Both sinus bradycardia and heart block were found more frequently soon after the onset of symptoms, the peak incidence of both occurring within one to two hours of 6-9hr 9-12hr 12-3bhr
group.bmj.com on April 15, 2017 -Published by http://heart.bmj.com/ Downloaded from extent of the infarction was to some extent correlated with the death rate, being highest with combined anterior and inferior infarction (40% mortality), followed closely by complete anterior infarction (38% mortality). There was also a high mortality of 75 per cent in 8 patients with left bundle-branch block alone.
Discussion
It has been clearly shown that the majority of deaths from acute myocardial infarction occur soon after the onset of the attack (Grace and Chadbourn, I969; Pantridge and Geddes, I967; Bainton and Peterson, I963; Yater et al., 1948) In the present series over 50 per cent of the patients had cardiac arrhythmia at some time before admission to hospital. Sinus bradycardia occurred in 9 per cent and was most frequent with inferior infarction (Pantridge, I968) . It was the commonest arrhythmia before cardiac arrest, due to an associated lowering of threshold for ventricular fibrillation (Han et al., I966) . Treatment of sinus bradycardia with intravenous atropine is strongly indicated. The most frequent ventricular arrhythmia was occasional unifocal ectopic beats not requiring treatment, and the most successful drug for the other ventricular tachyarrhythmias was intravenous lignocaine. Of the i6 patients with cardiac arrest -12 at home and 4 in the ambulance -only 3 survived to leave hospital, all of whom had had ventricular fibrillation, indicating the ominous prognosis of cardiac asystole, in spite of temporary resuscitation of 3 patients.
Heart block in I9 per cent, usually with inferior infarction, carried a poor prognosis, over half the patients dying, though intravenous hydrocortisone and atropine were successful in some patients. Cardiogenic shock in 23 patients also had a high mortality (72%), but very gratifying results were obtained in 3 moribund patients with intravenous noradrenaline, phenoxybenzamine, and massive doses of hydrocortisone.
The important question that remains to be group.bmj.com on April 15, 2017 -Published by http://heart.bmj.com/ Downloaded from answered is whether the coronary ambulance is worth while. The answer must obviously depend on how its value is assessed. In order to attempt an objective, as opposed to an emotional, evaluation of the coronary ambulance, two main aspects have been considered -the medical benefits and the financial implications. The medical benefits are shown in Table 6 and are assessed by dividing patients into 4 categories. i) Lives definitely saved -death regarded as inevitable in the absence of treatment.
2) Lives possibly saved -including serious arrhythmias often developing into ventricular fibrillation and severe left ventricular failure and heart block, both of which conditions may be associated with a high mortality in the absence of treatment.
3) Patients possibly improved -less serious arrhythmias not usually leading to catastrophic consequences, but possibly leading to cardiac embarrassment. 4) No immediate value.
The lives of 9 patients were saved in the first instance, but the 3 patients resuscitated from cardiac asystole subsequently died in hospital leaving 6 long-term survivors, all of whom are still alive. It was considered that lives possibly saved included 24 patients with potentially serious cardiac arrhythmias, 20 patients with severe left ventricular failure, and 7 with heart block; only 2 patients in this group died subsequently in hospital. An additional 58 patients may have improved as a result of treating less serious arrhythmias, such as sinus bradycardia, infrequent unifocal ectopics, atrial tachycardia, and atrial fibrillation. In this group it is not possible to predict accurately the likelihood of serious complications if left untreated. Nine patients in this group died later in hospital. It is of interest that the majority of deaths in the series came from patients who were found previously to have complications requiring treatment. Sixtyeight per cent of patients received no immediate benefit from the ambulance. Thus, just under a third of the 370 patients with acute myocardial infarction have benefited medically to a greater or lesser extent from the coronary ambulance.
The other important consideration is the cost-effectiveness of the service. The initial capital outlay, which is a non-recurrent expense, was £5,000 for the purpose-built ambulance and all the necessary monitoring and resuscitation equipment. None of this expenditure was a charge on the National Health Service, being raised by grants and voluntary 
